What is Synedica Retatrutide 40mg?
Synedica Retatrutide is a research-grade retatrutide formulation supplied in a pre-filled pen device. Each pen contains 40mg of retatrutide ā a triple receptor agonist targeting GLP-1, GIP and Glucagon receptors simultaneously. This triple mechanism is what distinguishes retatrutide from semaglutide (GLP-1 only) and tirzepatide (GLP-1 + GIP only).
Phase 2 clinical data published in the New England Journal of Medicine demonstrated an average 24.2% body weight reduction at 48 weeks ā the highest figure recorded for any compound in this class to date.
Why Order from Jeo Peptides UK?
- 14 years experience: Jeo has been a UK weight loss instructor and peptide specialist since 2011.
- Janoshik verified: Every batch independently tested ā not self-certified.
- Personal service: Jeo responds personally via WhatsApp. No bots, no Telegram.
- Cold chain delivery: Temperature-controlled from dispatch to your door. 48hr UK delivery.
- TikTok verified: 1,000+ verified reviews. @joeknowsthings0
Research Background
Retatrutide (LY3437943) is currently in Phase 3 TRIUMPH clinical trials. The unique glucagon receptor component increases resting energy expenditure ā a mechanism not found in semaglutide or tirzepatide ā making retatrutide the most potent compound in this class for research purposes.
